Chelsea Therapeutics International Ltd (CHTP)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

3530 TORINGDON WAY CHARLOTTE, NC 28277

Chelsea Therapeutics International, Ltd is a development stage pharmaceutical company that acquires and develops products for the treatment of a variety of human diseases. The Company strategy is to concentrate its efforts on acquiring and developing technologies for the treatment of rheumatoid arthritis, psoriasis, cancer and other immunological disorders.

View SEC Filings from CHTP instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CHTP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CHTP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHWIETERMAN WILLIAM D CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2014-06-23 0

WEISER MICHAEL

  • Director
No longer subject to file 2014-06-23 0

RIEHLE J NICK CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2014-06-23 0

HEWITT L ARTHUR CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2014-06-23 0

OLIVETO JOSEPH PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2014-06-23 0

SCHMIDT KEITH CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2014-06-23 0

ROBERTS MICHAEL J VP, BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2014-06-23 0

CLEMENS KEVAN

  • Director
No longer subject to file 2014-06-23 0

STOLL ROGER G PHD

  • Director
No longer subject to file 2014-06-23 0

RUECKERT WILLIAM DODGE

  • Director
No longer subject to file 2014-06-23 0

AUSTIN JOSIAH T

EL CORONADO HOLDINGS, LLC

  • 10% Owner
No longer subject to file 2012-12-14 0

LAU JOHNSON YIU NAM

  • Director
11,000 2012-06-04 0

PEDDER SIMON CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
488,180 2012-01-25 0

HARDMAN NORMAN PHD

  • Director
5,000 2012-01-25 0

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

HOVE ANDERS D

ROBERTS BRYAN E

  • 10% Owner
5,114,934 2011-02-02 0

HERSKOWITZ NEIL

  • Director
59,522 2008-01-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments